New free trade agreement might bring cheaper cancer drugs to India

Key Points

• Cheaper cancer drugs may be available in India due to the new free trade agreement, impacting healthcare costs.
• A key measurement showed that potential price reductions could enhance access to essential medications.
• Analysis of trade policies suggests a shift in pricing policies could lower trade barriers for pharmaceutical companies.
• This agreement may enable greater affordability of cancer treatments, although details on implementation remain pending.